Cannabidiol Market: Market Size & Forecast 2026

The global Cannabidiol market was valued at approximately $12.79 billion in 2025 and is projected to grow at a compound annual growth rate (CAGR) of about 17.64%, reflecting rapid mainstream adoption of CBD-based products. The market encompasses a wide range of offerings, including CBD oils, tinctures, capsules, edibles, topicals, beverages, and pharmaceutical preparations, derived from either hemp or marijuana. Public market estimates vary, with some sources placing the 2025 valuation closer to $15.44 billion and forecasting expansion to over $40 billion by the mid-2030s, underscoring strong consensus around sustained double-digit growth.

• •Hemp-derived CBD dominates global trade due to favorable legal status in most jurisdictions.
• •Product formats span tinctures, capsules, edibles, topicals, beverages, and isolates.
• •End use spans pharmaceuticals, nutraceuticals, cosmetics, food and beverage, and pet care.

Legalization momentum across North America, Europe, and parts of Latin America and Asia-Pacific is the single most powerful catalyst, opening new retail channels and reducing stigma around therapeutic cannabinoid use. Rising consumer preference for plant-based and natural wellness alternatives, combined with growing clinical interest in CBD's anxiolytic, anti-inflammatory, analgesic, and anticonvulsant properties, continues to broaden the addressable market. The expansion of e-commerce and direct-to-consumer distribution has further accelerated accessibility and product visibility worldwide.

• •Regulatory reforms in the U.S., EU, Canada, and emerging markets are unlocking new commercial opportunities.
• •Increasing scientific validation supports CBD use in pain management, anxiety, sleep, and epilepsy.
• •Mainstream retail and e-commerce channels are dramatically expanding consumer reach.

By source, hemp-based CBD accounts for the majority of global revenue, while marijuana-derived CBD remains significant in jurisdictions with full adult-use legalization, particularly in North America. By end use, medical and pharmaceutical applications represent the highest-value segment, followed by food and beverage, personal care and cosmetics, and recreational use. North America leads the global market in revenue terms, supported by mature U.S. and Canadian industries, while Europe is the fastest-growing region and Asia-Pacific is emerging rapidly due to evolving regulatory frameworks in countries such as Thailand, Australia, Japan, and South Korea.

• •North America holds the largest market share, anchored by the United States.
• •Europe is the fastest-growing region, driven by hemp cultivation and consumer wellness trends.
• •Asia-Pacific shows accelerating growth as regulatory frameworks mature across key economies.

What are the recent trends and outlook?

Key trends shaping the market's trajectory include the rise of CBD-infused functional beverages, expansion into pet wellness and cosmeceuticals, and growing investment in clinical trials aimed at securing pharmaceutical-grade indications. Regulatory tightening around labeling, testing, and health claims is raising quality standards and consolidating share toward compliant, well-capitalized producers. With strong tailwinds from legalization, scientific research, and consumer demand, the market is well positioned to sustain double-digit annual growth through at least the early 2030s.

• •Functional beverages and beauty/skincare applications represent the fastest-growing product categories.
• •Stricter quality, testing, and labeling regulations are reshaping competitive dynamics in favor of established brands.
• •Continued legalization and mainstream retail acceptance underpin a robust long-term growth outlook.